体素内不相干运动成像与动态增强MRI定量参数预测HER2零表达、低表达及阳性乳腺癌
回顾性纳入167例乳腺癌女性,比较HER2阳性(48例)、低表达(78例)和零表达(41例)的IVIM及DCE-MRI定量参数。瘤周水肿、组织学分级和Kep联合鉴别HER2阳性与低表达AUC为0.86;D*、Ktrans和Kep联合预测HER2阳性与零表达AUC为0.74。
要点
- 瘤周水肿、组织学分级和Kep是鉴别HER2阳性与低表达乳腺癌的独立预测因素。
- D*、Ktrans和Kep联合模型预测HER2阳性与零表达AUC为0.74,未优于单参数。
- IVIM和DCE-MRI定量参数可从不同角度预测乳腺癌HER2表达状态。
核心结论
- IVIM和DCE-MRI定量参数可从不同角度预测乳腺癌不同HER2表达状态,对治疗有提示意义。
研究设计与样本
- 回顾性研究纳入2019年12月至2023年12月行MRI的167例乳腺癌女性,分为HER2阳性48例、HER2低表达78例和HER2零表达41例,均行IVIM成像和DCE-MRI。
关键影像表现/征象
- 瘤周水肿、组织学分级和Kep联合鉴别HER2阳性与HER2低表达乳腺癌的AUC为0.86(95%CI:0.78,0.91)。
- D*、Ktrans和Kep联合模型预测HER2阳性与HER2零表达乳腺癌的AUC为0.74(95%CI:0.63,0.82)。
诊断标准与关键数值
- 瘤周水肿、组织学分级和Kep联合鉴别HER2阳性与HER2低表达乳腺癌的AUC为0.86(95%CI:0.78,0.91)。
- D*、Ktrans和Kep联合模型预测HER2阳性与HER2零表达乳腺癌的AUC为0.74(95%CI:0.63,0.82)。
- D*、Ktrans和Kep联合模型预测HER2阳性与HER2零表达的效能与单参数相比未提高(P > .05)。
临床应用与阅片要点
- 阅片时可关注瘤周水肿、组织学分级及Kep等参数,辅助鉴别HER2阳性与低表达乳腺癌。
- D*、Ktrans和Kep联合模型可用于预测HER2阳性与零表达乳腺癌,但其效能未优于单参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To explore the predictive value of quantitative parameters from intravoxel incoherent movement (IVIM) imging and dynamic contrast enhancement MRI (DCE-MRI) for HER2 expression in breast cancer.
MATERIALS AND METHODS: This retrospective study included 167 women with breast cancer who underwent MRI from December 2019 to December 2023, categorized into 48 HER2-positive, 78 HER2-low and 41 HER2-zero cancers. All patients underwent IVIM imaging and DCE-MRI. Statistical analyses, including one-way ANOVA, Kruskal-Wallis test and χ2 test, were employed to compare clinical data, MRI features, and MRI quantitative parameters including standard ADC(ADC), pure diffusion coefficient(D), perfusion-related diffusion coefficient(D*), perfusion fraction(f), volume transfer constant(Ktrans), extravascular extracellular interstitial volume ratio(Ve) and rate constant(Kep) between the three groups. Multivariable logistic regression was used to identify independent predictors for distinguishing HER2 expressions. The diagnostic efficacy of significant IVIM and DCE parameters for different HER2 expressions was analyzed using receiver operator characteristic (ROC) curves.
RESULTS: Peritumoral edema, histological grade and Kep achieved an AUC of 0.86(95%CI:0.78,0.91) in distinguishing HER2-positive tumors from HER2-low expressing tumors and were independent predictors for differentiating these two groups. Among HER2-positive and -zero breast cancers, the combined model of D*, Ktrans and Kep had an AUC of 0.74(95%CI:0.63,0.82) for the prediction of HER2-positive versus HER2-zero cancers, and its prediction efficiency was not improved compared with that of a single parameter(P > .05).
CONCLUSION: Quantitative parameters from intravoxel incoherent movement imaging and dynamic contrast enhancement MRI can predict different HER2 expressions in breast cancer from different perspectives, with implications for therapy.
引用
- Zhao S, Wang S, Li Y, et al. Quantitative Parameters of Intravoxel Incoherent Movement Imaging and Dynamic Contrast Enhancement MRI for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers. Acad Radiol. 2024. PMID: 39592385. doi:10.1016/j.acra.2024.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。